NEWS

APRIL 30TH 2020

Luspatercept receives positive CHMP opinion by EMA

​

https://www.ema.europa.eu/en/medicines/human/summaries-opinion/reblozyl

APRIL 3RD 2020

FDA approves luspatercept for anemia in adults with MDS

​

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-luspatercept-aamt-anemia-adults-mds